Pfaller, M. A., Shortridge, D., Harris, K. A., Garrison, M. W., DeRyke, C. A., DePestel, D. D., . . . Sader, H. S. (2021). Ceftolozane-tazobactam activity against clinical isolates of Pseudomonas aeruginosa from ICU patients with pneumonia: United States, 2015–2018. Elsevier.
Cita Chicago Style (17a ed.)Pfaller, Michael A., Dee Shortridge, Kelly A. Harris, Mark W. Garrison, C. Andrew DeRyke, Daryl D. DePestel, Pamela A. Moise, y Helio S. Sader. Ceftolozane-tazobactam Activity Against Clinical Isolates of Pseudomonas Aeruginosa from ICU Patients with Pneumonia: United States, 2015–2018. Elsevier, 2021.
Cita MLA (8a ed.)Pfaller, Michael A., et al. Ceftolozane-tazobactam Activity Against Clinical Isolates of Pseudomonas Aeruginosa from ICU Patients with Pneumonia: United States, 2015–2018. Elsevier, 2021.